China Medicine Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005
Period Ending	Sep '10 Sep 30, 2010	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008	Dec '07 Dec 31, 2007	Dec '06 Dec 31, 2006	Dec '05 Dec 31, 2005
Revenue	65.76	64.75	53.65	42.11	23.99	14.93
Revenue Growth (YoY)	-4.34%	20.70%	27.41%	75.50%	60.74%	43.51%
Cost of Revenue	43.75	45.77	38.07	29.71	15.02	8.66
Gross Profit	22	18.98	15.57	12.4	8.97	6.27
Selling, General & Admin	8.01	5.26	3.65	3.33	1.57	0.51
Research & Development	2.29	1.45	0.99	0.65	0.29	0.48
Operating Expenses	10.3	6.72	4.65	3.98	1.86	0.99
Operating Income	11.71	12.27	10.93	8.41	7.12	5.28
Interest & Investment Income	0.09	-	-	-	-	-
Other Non Operating Income (Expenses)	-0.01	-0.08	0.09	0.02	-0.2	0.41
EBT Excluding Unusual Items	11.56	12.18	11.01	8.43	6.92	5.69
Merger & Restructuring Charges	-	-	-	-	-0.93	-
Other Unusual Items	-2.07	-7.23	-	-	-	-
Pretax Income	9.48	4.95	11.01	8.43	5.98	5.69
Income Tax Expense	3.76	3.55	2.01	1.65	1.23	-
Earnings From Continuing Operations	5.72	1.4	9.01	6.78	4.75	5.69
Minority Interest in Earnings	0.31	0.32	0.12	0.09	0.03	-
Net Income	6.03	1.72	9.13	6.88	4.79	5.69
Net Income to Common	-0.11	1.72	9.13	6.88	4.79	5.69
Net Income Growth	-17.72%	-81.18%	32.73%	43.60%	-15.86%	93.57%
Shares Outstanding (Basic)	32	15	15	12	7	7
Shares Outstanding (Diluted)	32	15	15	14	8	7
Shares Change (YoY)	107.86%	0.67%	12.08%	78.45%	17.21%	-
EPS (Basic)	-0.00	0.11	0.60	0.56	0.65	0.87
EPS (Diluted)	-0.01	0.11	0.60	0.50	0.63	0.87
EPS Growth	-	-81.67%	20.00%	-20.64%	-27.59%	93.26%
Free Cash Flow	6.43	13.52	1.54	-2.7	-3.04	1.01
Free Cash Flow Per Share	0.20	0.88	0.10	-0.20	-0.40	0.15
Gross Margin	33.46%	29.32%	29.03%	29.44%	37.41%	42.00%
Operating Margin	17.80%	18.94%	20.37%	19.98%	29.66%	35.37%
Profit Margin	-0.17%	2.65%	17.01%	16.33%	19.96%	38.12%
Free Cash Flow Margin	9.78%	20.88%	2.88%	-6.41%	-12.69%	6.74%
EBITDA	13.41	13.28	11.35	8.72	7.28	5.38
EBITDA Margin	20.39%	20.51%	21.15%	20.71%	30.33%	36.07%
D&A For EBITDA	1.7	1.01	0.42	0.3	0.16	0.1
EBIT	11.71	12.27	10.93	8.41	7.12	5.28
EBIT Margin	17.80%	18.94%	20.37%	19.98%	29.66%	35.37%
Effective Tax Rate	39.66%	71.68%	18.21%	19.56%	20.55%	-
Revenue as Reported	65.76	64.75	53.65	42.11	23.99	14.93
Advertising Expenses	-	0.56	0.54	0.41	0.07	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.